Christopher Koh, MD, MHSc

Biography

Dr. Christopher Koh is the Clinical Director for the Division of Intramural Research (DIR) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK DIR has 91 Principal Investigators, 70 Staff Scientists/Clinicians, and 350 fellows and trainees organized into 8 Labs and 10 Branches with additional support from 10 core facilities. This program has annual operating budget of approximately $217 million of which approximately half is allocated towards clinical research and associated personnel overseen by Dr. Koh. Areas of clinically relevant focus includes diabetes and other endocrine and metabolic diseases; digestive diseases; liver diseases; obesity; and kidney, urologic, and hematologic diseases.

As a Senior Research Physician at the NIH, Dr. Koh's research is focused on studying novel therapeutics in viral hepatitis, clinical biomarkers of liver injury, liver disease in rare populations, and drug induced liver injury. In the area of Drug Induced Liver Injury, Dr. Koh serves as an Ad Hoc Member of the External Expert Review Committee for LiverTox and as a principal investigator with the Drug Induced Liver Injury Network where the NIH Clinical Center serves as a referral site.

Dr. Koh earned his MD from Saba University School of Medicine and his MHSc in Clinical Research from Duke University School of Medicine. After completing his internal medicine training in Baltimore, MD, he completed a clinical hepatology fellowship with the NIDDK and then a gastroenterology fellowship at the University of Maryland. He then joined the Liver Diseases Branch of the NIDDK in 2013 and was promoted to Deputy Clinical Director in 2019 and Clinical Director in 2022. From 2013 to 2023, Dr. Koh also served as the fellowship program director for NIDDK's clinical fellowships in Gastroenterology and Hepatology. Dr. Koh is a fellow of the American College of Physicians (ACP) and the American Association for the Study of Liver Diseases (AASLD). He has published more than 150 peer-reviewed journal articles and book chapters and has served on the editorial board for various Gastroenterology and Hepatology journals